Financial reports
ARS
2023 FY
Annual report to shareholders
25 Apr 24
10-K
2023 FY
Annual report
15 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2021 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K/A
Departure of Directors or Certain Officers
16 Apr 24
8-K
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
14 Mar 24
8-K
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
13 Feb 24
8-K
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
21 Dec 23
8-K
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
14 Nov 23
8-K
Company Pursuing Multiple Additional Strategic Opportunities
30 Oct 23
8-K
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
8-K
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
11 May 23
8-K
Entry into a Material Definitive Agreement
9 May 23
Registration and prospectus
S-3
Shelf registration
21 Dec 23
S-3
Shelf registration
3 Aug 23
S-3
Shelf registration
3 Aug 23
S-8
Registration of securities for employees
17 Jun 21
424B5
Prospectus supplement for primary offering
19 Nov 20
424B5
Prospectus supplement for primary offering
18 Nov 20
424B5
Prospectus supplement for primary offering
9 Aug 19
424B5
Prospectus supplement for primary offering
7 Aug 19
S-3
Shelf registration
17 Jul 19
S-3
Shelf registration
2 Jul 19
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
20 Jan 23
DEF 14A
Definitive proxy
23 Dec 22
DEF 14A
Definitive proxy
2 May 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
DEFA14A
Additional proxy soliciting materials
26 May 20
Other
EFFECT
Notice of effectiveness
2 Jan 24
UPLOAD
Letter from SEC
27 Dec 23
CORRESP
Correspondence with SEC
27 Dec 23
EFFECT
Notice of effectiveness
14 Aug 23
EFFECT
Notice of effectiveness
14 Aug 23
CORRESP
Correspondence with SEC
9 Aug 23
CORRESP
Correspondence with SEC
9 Aug 23
UPLOAD
Letter from SEC
8 Aug 23
UPLOAD
Letter from SEC
8 Aug 23
UPLOAD
Letter from SEC
4 May 23
Ownership
4
Alexandria Forbes
8 Apr 24
4
Alexandria Forbes
14 Mar 24
4
Richard Giroux
4 Mar 24
SC 13D/A
PERCEPTIVE ADVISORS LLC
14 Feb 24
SC 13G/A
Prosight Management, LP
13 Feb 24
SC 13G/A
ADAGE CAPITAL PARTNERS GP, L.L.C.
7 Feb 24
4/A
Robert K Zeldin
18 Jan 24
4
Richard Giroux
17 Jan 24
4
Robert K Zeldin
17 Jan 24
4
Alexandria Forbes
17 Jan 24